# Sakai Chemical Industry Co.,Ltd.: business model and financials

> Latest period: FY ending Mar 2026, consolidated, J-GAAP
> Unit: JPY millions
> Sources: 有価証券報告書－第131期(2025/04/01－2026/03/31) (S100YICQ)
> Page: https://vizora.meequs.com/en/company/sakai-chemical-industry
> Retrieved: 2026-09-30T17:59:48.890Z

## Company

Sakai Chemical Industry, founded in 1918, is a company in Chemicals listed on TSE Prime. It has 1,942 employees (consolidated).

| Field | Value |
| --- | ---: |
| Legal name | SAKAI CHEMICAL INDUSTRY CO., LTD. |
| Ticker | 4078 |
| Stock price | View on Yahoo Finance (https://finance.yahoo.co.jp/quote/4078.T) |
| Listing | TSE Prime |
| Head office | 堺市堺区戎島町5丁2番地 |
| Representative (per filing) | 代表取締役社長 矢倉 敏行 |
| Founded | Jun 1918 |
| Share capital | ¥21.8B |
| Employees (consolidated) | 1,942 |
| Average salary (parent only) | ¥6.5M |
| Fiscal year end | March |
| Website | sakai-chem.co.jp (https://sakai-chem.co.jp/) |
| Corporate number | 4120101002532 |
| EDINET | E00780 |
| Industries (Vizora) | Chemicals, Electronic Components, Pharmaceuticals |

> Profile source: annual securities report (S100YICQ, filed 2026-06-24). As of filing

## Five-axis industry profile

Primary industry: Chemicals (2026-03-31)

| Axis | Industry percentile | Peers |
| --- | ---: | ---: |
| Revenue growth | 6.8 | 96 |
| Profitability | 55.5 | 100 |
| Cash conversion | 78.6 | 96 |
| Efficiency | 43.5 | 100 |

Each axis is shown independently. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

## Key points (generated from figures)

- About 16% of Sakai Chemical Industry's sales come from Plastic additives, with Electronic materials and Titanium dioxide and zinc products (without Cosmetics Materials) making up much of the rest.
- Out of every ¥100 of sales, about ¥8 is left as operating profit.
- Revenue changed -3.5% from the prior year, operating profit +5.9%.

## Company structure

- Segment revenue mix: Plastic additives 16.2%、Electronic materials 16.0%、Titanium dioxide and zinc products (without Cosmetics Materials) 14.4%、Medical business 11.8%、Organic chemicals 10.1%
- Revenue → net income: ¥81447000000 → ¥2877000000
- Net income → operating cash flow: ¥2877000000 → ¥14479000000（difference ¥11602000000）
- Main uses of operating cash flow: CapEx ¥6070000000 / dividends ¥2179000000 / buybacks ¥2500000000
- Change in cash: ¥-708000000
Segment shares use total reported segment revenue, which may include inter-segment sales. The cash bridge is operating cash flow minus net income and combines non-cash items and working-capital effects.

## Key figures at a glance

| Metric | Value | Note |
| --- | ---: | ---: |
| Revenue | ¥81.4B |  |
| Operating income | ¥6.45B | Margin 7.9% |
| Net income | ¥2.75B | Margin 3.4% |
| Free cash flow | ¥8.41B |  |
| Largest business | Plastic additives | of segment revenue 16.2% |
| Employees (consolidated) | 1,942 |  |
| EPS | ¥51.15 |  |
| Diluted EPS | ¥45.68 |  |
| Book value per share | ¥3025.98 |  |
| Equity ratio | 66.3% |  |
| Shares outstanding | 16,000,000 |  |
| Treasury shares | 688,800 |  |
| Shareholders | 7,769 |  |
| Average salary (parent only) | ¥6.5M | Filing company only |
| Cash ratio | 13.2% | Cash ÷ revenue 19.0% |
| Vs. industry median margin | +0.4 pp | Chemicals |
| ROE | 3.7% | Derived from disclosed figures |
| ROA | 2.3% | Derived from disclosed figures |

## Notable figures

- FY2026, operating cash flow is 5.3× net income
- FY2026, buybacks were 1.1× dividends
- FY2026, employees -2% while operating income rose 6%

## What changed in 5 years

| Metric | FY ending Mar 2021 | FY ending Mar 2026 | Change |
| --- | ---: | ---: | ---: |
| Revenue | ¥84918000000 | ¥81447000000 | -4.1% |
| Operating income | ¥4304000000 | ¥6452000000 | +49.9% |
| Operating margin | 5.1% | 7.9% | +2.9 pp |
| Employees | 2,009 people | 1,942 people | -3.3% |
| Cash and equivalents | ¥11153000000 | ¥15444000000 | +38.5% |

### Change in segment revenue mix

Span: FY ending Mar 2021 → FY ending Mar 2026. Stable segment keys are connected; unmatched shares are marked as new or reorganized. Shares use total segment revenue.

| Flow | Revenue share |
| --- | ---: |
| 化学 → 事業再編・廃止 | 90.5% |
| 医療 → 事業再編・廃止 | 9.5% |
| 新設・再編 → 電子材料 | 16.0% |
| 新設・再編 → 化粧品材料 | 2.4% |
| 新設・再編 → 有機化学品 | 10.1% |
| 新設・再編 → 衛生材料 | 7.5% |
| 新設・再編 → 受託加工 | 9.4% |
| 新設・再編 → 酸化チタン・亜鉛製品 | 14.4% |
| 新設・再編 → 樹脂添加剤 | 16.2% |
| 新設・再編 → 触媒 | 4.9% |
| 新設・再編 → 無機材料 | 7.2% |
| 新設・再編 → 医療事業 | 11.8% |

Segment revenue source references: 12 (derived)

## Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: latest revenue. CAGR requires at least two comparable years.

| Segment | CAGR span | Revenue CAGR | Latest revenue | Operating margin | Source refs |
| --- | ---: | ---: | ---: | ---: | ---: |
| Plastic additives | 2 years | -7.1% | ¥11507000000 | 9.3% | 2 |
| Electronic materials | 2 years | +20.3% | ¥11377000000 | 16.0% | 2 |
| Titanium dioxide and zinc products (without Cosmetics Materials) | 2 years | -14.2% | ¥10244000000 | 11.9% | 2 |
| Medical business | 2 years | +2.1% | ¥8391000000 | -0.6% | 2 |
| Organic chemicals | 2 years | -4.0% | ¥7185000000 | 10.0% | 2 |
| Contract processing | 2 years | +3.8% | ¥6677000000 | 12.1% | 2 |
| Hygienic products | 2 years | +0.1% | ¥5353000000 | 8.5% | 2 |
| Inorganic materials | 2 years | +1.3% | ¥5100000000 | 23.5% | 2 |
| Catalysts | 2 years | +4.7% | ¥3462000000 | 18.7% | 2 |
| Cosmetics materials | 2 years | -17.0% | ¥1720000000 | -25.4% | 2 |

## Income statement（FY ending Mar 2026, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Revenue | 81,447 | 100.0% | S100YICQ |
| Cost of revenue | 60,742 | 74.6% | S100YICQ |
| Gross profit | 20,704 | 25.4% | S100YICQ |
| SG&A | 14,252 | 17.5% | S100YICQ |
| Operating income | 6,452 | 7.9% | S100YICQ |
| Ordinary income | 6,545 | 8.0% | S100YICQ |
| Pretax income | 4,506 | 5.5% | S100YICQ |
| Income tax | 1,629 | 2.0% | S100YICQ |
| Net income | 2,877 | 3.5% | S100YICQ |
| Net income attributable to owners | 2,752 | 3.4% | S100YICQ |

## Per ¥100 of revenue（FY ending Mar 2026）

| Part | JPY |
| --- | ---: |
| Cost of revenue | 75 |
| SG&A | 17 |
| Operating income | 8 |
| (Ref.) Net income | 3 |

### Margin funnel

Gross margin 25.4% → Operating margin 7.9% → Net margin 3.4%
Derived from reported figures (DERIVED).

## Revenue and profit pattern

Pattern: Revenue down, profit up
Revenue growth: -3.5%; Core profit growth: +5.9%
Operating leverage (core profit growth ÷ revenue growth): -1.68×
Calculated from comparable annual consolidated filings.

## Year over year（FY ending Mar 2025 → FY ending Mar 2026、JPY mn）

| Metric | Prior | Current | Change | % change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 84,409 | 81,447 | -2,962 | -3.5% |
| Gross profit | 20,282 | 20,704 | 422 | +2.1% |
| Operating income | 6,093 | 6,452 | 359 | +5.9% |
| Net income attributable to owners | 5,013 | 2,752 | -2,261 | -45.1% |
| Operating cash flow | 12,005 | 14,479 | 2,474 | +20.6% |
| Free cash flow | 5,057 | 8,409 | 3,352 | +66.3% |

## History（JPY mn）

| Period | Revenue | Op. income | Op. margin | Net income | Op. CF | FCF | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FY ending Mar 2020 | 87,177 | 4,015 | 4.6% | 2,535 | 6,454 | -1,949 | S100LJGA |
| FY ending Mar 2021 | 84,918 | 4,304 | 5.1% | -2,803 | 7,826 | -1,741 | S100Q019 |
| FY ending Mar 2022 | 80,135 | 7,494 | 9.4% | 6,747 | 6,567 | 1,503 | S100R306 |
| FY ending Mar 2023 | 83,861 | 4,407 | 5.3% | 2,344 | 773 | -1,885 | S100TSNK |
| FY ending Mar 2024 | 82,105 | 2,942 | 3.6% | -7,092 | 6,866 | 2,842 | S100W3IO |
| FY ending Mar 2025 | 84,409 | 6,093 | 7.2% | 5,013 | 12,005 | 5,057 | S100YICQ |
| FY ending Mar 2026 | 81,447 | 6,452 | 7.9% | 2,752 | 14,479 | 8,409 | S100YICQ |

## People and productivity（FY ending Mar 2026, consolidated, J-GAAP）

| Metric | Value |
| --- | ---: |
| Revenue per employee (consolidated) | ¥41.9M |
| Operating income per employee (consolidated) | ¥3.3M |
| Net income per employee (consolidated) | ¥1.4M |

Employees, revenue and profit are consolidated. Average annual salary is a separate parent-company figure. Calculated from disclosed figures (DERIVED).

| History | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Employees (consolidated) | 2,024 | 2,013 | 1,999 | 1,972 | 1,942 |
| Average salary (parent company) | ¥5.9M | ¥6.2M | ¥6M | ¥6.2M | ¥6.5M |
| Average age (parent company) | 39.9 years | 40.1 years | 40.4 years | 42.3 years | 41.7 years |
| Average tenure (parent company) | 16.0 years | 15.7 years | 15.7 years | 15.4 years | 16.5 years |

Year over year: Employees (consolidated) -1.5% · Revenue (consolidated) -3.5%

## Segments（FY ending Mar 2026, consolidated, J-GAAP、JPY mn）

| Segment | Revenue | Share | Op. income | Op. margin |
| --- | ---: | ---: | ---: | ---: |
| Electronic materials | 11,377 | 16.0% | 1,816 | 16.0% |
| Cosmetics materials | 1,720 | 2.4% | -437 | -25.4% |
| Organic chemicals | 7,185 | 10.1% | 721 | 10.0% |
| Hygienic products | 5,353 | 7.5% | 457 | 8.5% |
| Contract processing | 6,677 | 9.4% | 805 | 12.1% |
| Titanium dioxide and zinc products (without Cosmetics Materials) | 10,244 | 14.4% | 1,222 | 11.9% |
| Plastic additives | 11,507 | 16.2% | 1,068 | 9.3% |
| Catalysts | 3,462 | 4.9% | 648 | 18.7% |
| Inorganic materials | 5,100 | 7.2% | 1,200 | 23.5% |
| Medical business | 8,391 | 11.8% | -48 | -0.6% |

### segmentMix — Revenue and profit mix

Calculated from disclosed figures (DERIVED). Shares use total segment revenue and total positive segment profit respectively. Difference = profit share − revenue share (pt). Inter-segment sales may prevent reconciliation to company revenue.

| Segment | Revenue share | Profit share | Difference (pt) | Margin |
| --- | ---: | ---: | ---: | ---: |
| Electronic materials | 16.0% | 22.9% | 6.9 | 16.0% |
| Cosmetics materials | 2.4% | — | — | -25.4% |
| Organic chemicals | 10.1% | 9.1% | -1.0 | 10.0% |
| Hygienic products | 7.5% | 5.8% | -1.8 | 8.5% |
| Contract processing | 9.4% | 10.1% | 0.7 | 12.1% |
| Titanium dioxide and zinc products (without Cosmetics Materials) | 14.4% | 15.4% | 1.0 | 11.9% |
| Plastic additives | 16.2% | 13.5% | -2.7 | 9.3% |
| Catalysts | 4.9% | 8.2% | 3.3 | 18.7% |
| Inorganic materials | 7.2% | 15.1% | 7.9 | 23.5% |
| Medical business | 11.8% | — | — | -0.6% |

Loss-making segment (excluded from profit shares): Cosmetics materials -437 JPY mn

Loss-making segment (excluded from profit shares): Medical business -48 JPY mn

Segment → industry: Electronic materials → Chemicals / Electronic materials → Electronic Components / Cosmetics materials → Chemicals / Organic chemicals → Chemicals / Hygienic products → Chemicals / Contract processing → Chemicals / Titanium dioxide and zinc products (without Cosmetics Materials) → Chemicals / Plastic additives → Chemicals / Catalysts → Chemicals / Inorganic materials → Chemicals / Medical business → Pharmaceuticals

## Revenue by geography

No geographic revenue breakdown was disclosed.

## Cash flow（FY ending Mar 2026, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Operating cash flow | 14,479 | 17.8% | S100YICQ |
| Capital expenditure | 6,070 | 7.5% | S100YICQ |
| Free cash flow | 8,409 | 10.3% | 算出 |
| Investing cash flow | -4,645 | -5.7% | S100YICQ |
| Financing cash flow | -10,592 | -13.0% | S100YICQ |
| Dividends paid | 2,179 | 2.7% | S100YICQ |
| Share buyback | 2,500 | 3.1% | S100YICQ |
| Change in cash | -708 | -0.9% | S100YICQ |
| Cash and equivalents | 15,444 | 19.0% | S100YICQ |

## Balance sheet

Figures are as of each fiscal year end. Derived values are marked as such in the source column. Lease liabilities are excluded from interest-bearing debt.

| Metric | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | 10,549 | 12,188 | 16,475 | 16,153 | 15,444 | S100TSNK, S100W3IO, S100YICQ |
| Total assets | 123,919 | 128,021 | 125,445 | 123,319 | 117,216 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Net assets | 82,708 | 84,717 | 75,466 | 79,386 | 78,923 | S100TSNK, S100W3IO, S100YICQ |
| Share capital | 21,838 | 21,838 | 21,838 | 21,838 | 21,838 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Trade receivables | 29,908 | 27,555 | 25,497 | 22,800 | 20,904 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Property, plant and equipment | 48,134 | 46,761 | 40,463 | 44,520 | 43,167 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Intangible assets excluding goodwill | 1,519 | 1,368 | 1,168 | 1,050 | 1,132 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Goodwill | 1,146 | 1,012 | 888 | 777 | 666 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Investment securities | 4,859 | 4,838 | 6,206 | 5,120 | 6,215 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Current assets | 65,496 | 72,101 | 76,042 | 71,416 | 65,352 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Current liabilities | 26,771 | 29,237 | 31,757 | 27,910 | 25,272 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Trade payables | 9,452 | 8,610 | 9,066 | 8,561 | 8,632 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Short-term borrowings | 8,202 | 13,175 | 15,108 | 11,512 | 8,357 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Long-term borrowings | 8,756 | 8,467 | 8,930 | 7,406 | 4,643 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Total liabilities | 41,211 | 43,304 | 49,978 | 43,933 | 38,293 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Non-controlling interests | 3,854 | 4,229 | 1,074 | 1,095 | 1,214 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Equity attributable to owners of parent | 77,772 | 78,863 | 71,183 | 74,679 | 72,771 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Retained earnings | 41,433 | 42,482 | 34,334 | 37,767 | 38,339 | S100R306, S100TSNK, S100W3IO, S100YICQ |
| Treasury stock | -1,798 | -1,751 | -1,716 | -1,701 | -1,706 | S100R306, S100TSNK, S100W3IO, S100YICQ |

### Assets and funding mix

| Assets | Share | Source |
| --- | ---: | ---: |
| Cash | 13% | S100YICQ |
| Receivables | 18% | S100YICQ |
| Property, plant and equipment | 37% | S100YICQ |
| Intangibles and goodwill | 2% | S100YICQ |
| Investment securities | 5% | S100YICQ |
| Other assets | 25% | S100YICQ |

| Funding source | Share | Source |
| --- | ---: | ---: |
| Trade payables | 8% | S100YICQ |
| Other liabilities | 25% | S100YICQ |
| Equity | 67% | S100YICQ |

### Balance sheet history

| Metric | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Total assets | 123,919 | 128,021 | 125,445 | 123,319 | 117,216 |
| Equity | 82,708 | 84,717 | 75,466 | 79,386 | 78,923 |
| Interest-bearing debt | — | — | — | — | — |
| Cash | 10,549 | 12,188 | 16,475 | 16,153 | 15,444 |

## Asset intensity and goodwill

Ratios are derived from reported values. Goodwill is used only when separately reported, never inferred from combined intangible assets.

| Metric | Value | Sources |
| --- | ---: | ---: |
| Asset intensity (fixed assets ÷ revenue) | 53.0% | S100YICQ |
| Fixed assets ÷ total assets | 36.8% | S100YICQ |
| Goodwill ÷ parent equity | 0.9% | S100YICQ |

Goodwill over 4 years: 1,146 → 666 JPY; total investing cash flow: -18,596 JPY. This does not imply causation.

### Cash quality

Net cash = cash − interest-bearing debt. Net debt ratio = (interest-bearing debt − cash) ÷ positive operating cash flow. Omit when debt components are incomplete; other ratios are derived from reported figures.

| Metric | Value |
| --- | ---: |
| Cash ratio (cash ÷ total assets) | 13.2% |
| Cash ÷ revenue | 19.0% |
| Net cash (cash − interest-bearing debt) | — |
| Net debt ÷ operating cash flow | — |
| Cash conversion (operating CF ÷ operating income) | 224.4% |
| Cash vs. profit gap | 11,727 JPY mn (of net income 426.1%) |
| Shareholder returns / net income | 170.0% |
| Shareholder returns / FCF | 55.6% |
| Shareholder payments — dividends / net income | 79.2% |
| Shareholder payments — dividends / FCF | 25.9% |
| CapEx intensity (capex ÷ revenue) | 7.5% |
| Investing CF relative to operating CF | 32.1% |

## ROA and ROE

ROE is decomposed into net margin × asset turnover × financial leverage. Leverage can raise ROE, so the ratio alone does not assess a company's condition. Ending balances are used without a prior year; total equity approximates parent equity when unavailable.

| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE | Sources |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| 2022 | 8.4% | 0.65× | 5.4% | 1.59× | 8.7% | S100R306 |
| 2023 | 2.8% | 0.67× | 1.9% | 1.61× | 3.0% | S100TSNK |
| 2024 | — | —× | -5.6% | —× | — | S100W3IO |
| 2025 | 5.9% | 0.68× | 4.0% | 1.71× | 6.9% | S100YICQ |
| 2026 | 3.4% | 0.68× | 2.3% | 1.63× | 3.7% | S100YICQ |

## Ownership

| Counterparty | Relation | Ratio | As of |
| --- | ---: | ---: | ---: |
| 日本マスタートラスト信託銀行株式会社（信託口） | Major shareholder | 14.9% | 2026-03-31 |
| 株式会社日本カストディ銀行（信託口） | Major shareholder | 8.9% | 2026-03-31 |
| CEPLUX-THE INDEPENDENT UCITS PLATFORM 2 (常任代理人 シティバンク、エヌ・エイ東京支店) | Major shareholder | 7.0% | 2026-03-31 |
| RE FUND 107-CLIENT AC (常任代理人 シティバンク、エヌ・エイ東京支店） | Major shareholder | 2.9% | 2026-03-31 |
| 明治安田生命保険相互会社 （常任代理人 株式会社日本カストディ銀行） | Major shareholder | 2.8% | 2026-03-31 |
| 日本生命保険相互会社 (常任代理人 日本マスタートラスト信託銀行株式会社） | Major shareholder | 2.7% | 2026-03-31 |
| BNYMSANV RE BNYMIL RE WS ZENNOR JAPAN EQUITY INCOME FUND （常任代理人 株式会社三菱UFJ銀行） | Major shareholder | 2.1% | 2026-03-31 |
| STATE STREET BANK AND TRUST COMPANY 505223 (常任代理人 株式会社みずほ銀行) | Major shareholder | 2.1% | 2026-03-31 |
| 堺化学取引先持株会 | Major shareholder | 1.8% | 2026-03-31 |
| DFA INTL SMALL CAP VALUE PORTFOLIO （常任代理人 シティバンク、エヌ・エイ東京支店） | Major shareholder | 1.6% | 2026-03-31 |

## Sources

| Document | ID | Published | URL |
| --- | ---: | ---: | ---: |
| 有価証券報告書－第131期(2025/04/01－2026/03/31) | S100YICQ | 2026-06-24 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YICQ,, |
| 有価証券報告書－第130期(2024/04/01－2025/03/31) | S100W3IO | 2025-06-25 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100W3IO,, |
| 有価証券報告書－第129期(2023/04/01－2024/03/31) | S100TSNK | 2024-06-26 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100TSNK,, |
| 有価証券報告書－第128期(2022/04/01－2023/03/31) | S100R306 | 2023-06-28 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100R306,, |
| 訂正有価証券報告書－第127期(2021/04/01－2022/03/31) | S100Q019 | 2023-01-23 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100Q019,, |
| 有価証券報告書－第126期(令和2年4月1日－令和3年3月31日) | S100LJGA | 2021-06-25 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100LJGA,, |

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).